What's on the web on your pursuit, hobbies, interests and worries

MyeloproliferativeDisorders news

Characteristics of Polycythemia Vera

Targeted Oncology - Oct 18, 2016
Harry Erba, MD, PhD: The chronic myeloproliferative disorders were first classified by William Dameshek around 1950. He was a physician practicing in Boston, and he recognized that there were patients that presented with a constitution of findings that ...

Understanding Drivers of Progression in Myelofibrosis

OncLive - Sep 29, 2016
Daniel J. DeAngelo, MD, PhD: Myelofibrosis is part of the constellation of diseases known as the chronic myeloproliferative disorders. It's an interesting disease. It has a chronicity to it; thus, the name. Patients can have a wide range of clinical ...

Trial watch: Telomerase inhibitor shows promise in myeloproliferative disorders

Nature.com - Oct 30, 2015
Telomerase inhibitors have been tried as therapies for numerous cancers, including breast cancer and non-small-cell lung cancer, but have not been effective in clinical trials. Two recently published Phase II trials, however, have found that treatment ...

Myeloproliferative Disorders - premium items on eBay

NEW Molecular Basis of Chronic Myeloproliferative Disorders


Myeloproliferative Disorders (Hematologic Malignancies) by Junia V. Melo


NEW Molecular Basis of Chronic Myeloproliferative Disorders by Petro E. Petrides


>> Go to all great Myeloproliferative Disorders deals on eBay

Myeloproliferative Disorders books

Chronic Myeloproliferative Disorders

With the new classification of chronic myeloproliferative disorders, and the rise of interest in molecularly targeted therapies, this timely text brings together international experts on the topic to discuss the current technologies and their implications for the treatment of patients.

This title comprehensively covers chronic myeloid leukemia and Ph-negative chronic myeloproliferative disorders and is an essential resource for all practitioners in Hematologic Oncology.

>> More info on Amazon

Harrison's Hematology and Oncology

by: Dan Longo

The authority of Harrison's in a handy, full-color paperback devoted exclusively to Hematology and Oncology

A Doody's Core Title for 2011!

Featuring the chapters on Hematology and Oncology that appear in the landmark Harrison's Principles of Internal Medicine, 17e, this compact clinical companion delivers all the latest knowledge in the field, backed by the scientific rigor and reliability that have defined Harrison's.

You'll find coverage that reflects the expertise of renowned editors and contributors -- presented in a carry-anywhere format that makes it ideal for the classroom, the wards, or the point of care.
>> More info on Amazon

Polycythemia Vera and the Myeloproliferative Disorders, 1e

by: Louis R. Wasserman MD, Paul D. Berk MD, Nathaniel I. Berlin MD PhD
This comprehensive reference on polycythemia vera and the myeloproliferative disorders provides clinical information on these diseases. Written by recognized experts from the Polycythemia Vera Study Group, this text presents three decades of collective investigation in this field. It includes treatment of thrombocythemia with anagrelide, secondary polycythemia, chronic myelocytic leukemia, therapeutic recommendations for polycythemia vera, and much more.
>> More info on Amazon

>> Go to all Myeloproliferative Disorders books

Myeloproliferative Disorders pictures on the web

>> Show

Myeloproliferative Disorders videos

Haematology Myeloproliferative Disorders

A review of myeloproliferative disorders.

Chronic Myeloproliferative disorders [USMLE]

Myeloproliferative diseases are a heterogeneous group of disorders characterized by cellular proliferation of one or more hematologic cell lines in the peripheral ...

Myeloproliferative Disorders VOPP Dr. Alex - NCD 1 Bastyr

This is the VOPP for the introduction to MPD and MPN.

5th lecture Myeloproliferative disorders


Myeloproliferative Disorders: Can Prognosis be Predicted?

Dr. Ruben Mesa describes various tools used to better predict disease behavior, specifically symptoms, among polycythemia vera (PV), essential ...